共 50 条
- [45] Corticosteroid discontinuation and clinical outcomes in patients with moderately to severely active Crohn's disease treated with upadacitinib JOURNAL OF CROHNS & COLITIS, 2023, 17 : I104 - I106
- [46] Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease JOURNAL OF CROHNS & COLITIS, 2013, 7 (03): : 213 - 221
- [48] Adalimumab maintains clinical remission and response in patients with active Crohn's disease: Results of the CHARM trial AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S458 - S458